Patent Assignment
Reel/Frame 072473/0861
Security Interest
Recorded: 2025-08-15
Pages: 24
Assignor
BT BIDCO, INC.
Executed: 2025-08-15
Assignee
GLAS USA LLC
3 SECOND STREET, SUITE 206, JERSEY CITY, NEW JERSEY, 07311
Covered Properties
(181)
Ingestible Medical Device
Application:
61/600,029 →
Ingestible Medical Device
Electromechanical Pill Device with Localization Capabilities
Application:
62/055,244 →
Electromechanical Pill Device with Localization Capabilities
Electromechanical Pill Device with Localization Capabilities
Electromechanical Pill Device with Localization Capabilities
Systems and Methods for Obtaining Samples Using Ingestible Devices
Application:
62/376,688 →
Sampling Systems and Related Materials and Methods
Sampling Systems and Related Materials and Methods
Application:
16/787,557 →
Publication:
US US20200170627A1
Electromechanical Ingestible Device for Delivery of a Dispensable Substance
Application:
62/478,955 →
Ingestible Device for Delivery of a Dispensable Substance
Electromechanical Ingestible Device for Delivery of a Dispensable Substance
Application:
18/360,744 →
Publication:
US US20230363663A1
Compositions, Methods, and Devices for Bacteria Detection and Quantitation
Application:
62/431,297 →
Methods for Collecting and Testing Bacteria Containing Samples from Within the Gastrointestinal Tract
Ingestible Device Recovery System
Application:
62/434,188 →
Ingestible Device Recovery System
Ingestible Device for Sampling, Diluting and Culturing a Biological Sample
Application:
62/434,320 →
Ingestible Device and Associated Methods
Application:
62/434,797 →
Ingestible Device and Associated Methods
Application:
62/570,411 →
Ingestible Device and Associated Methods
Application:
17/745,549 →
Publication:
US US20220273196A1
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/434,363 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/479,118 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/545,240 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/583,768 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
16/465,360 →
Publication:
US US20190343425A1
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/434,348 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/478,744 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/545,188 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/583,797 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor Released Using an Ingestible Device
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor Released Using an Ingestible Device
Application:
18/174,603 →
Publication:
US US20250230229A1
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/434,369 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/478,863 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/545,220 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/583,804 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
16/467,744 →
Publication:
US US20200253506A1
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application:
62/434,366 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application:
62/478,840 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application:
62/545,219 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Agonist
Application:
62/583,800 →
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Modulator
Treatment of a Disease of the Gastrointestinal Tract with a Tlr Modulator
Application:
17/864,319 →
Publication:
US US20230019619A1
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application:
62/434,371 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application:
62/478,846 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application:
62/545,311 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Application:
62/583,823 →
Treatment of a Disease of the Gastrointestinal Tract with a SMAD7 Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/434,374 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/478,919 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/545,380 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/583,832 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor and Devices
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor and Devices
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor and Devices
Application:
18/384,378 →
Publication:
US US20240252425A1
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/434,372 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/478,937 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/545,157 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/583,861 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses Thereof
Application:
18/989,485 →
Publication:
US US20250222146A1
Treatment of a Disease of the Gastrointestinal Tract with Stem Cells
Application:
62/479,027 →
Treatment of a Disease of the Gastrointestinal Tract with Live Biotherapeutics
Application:
62/545,297 →
Treatment of a Disease of the Gastrointestinal Tract with Live Biotherapeutics
Application:
62/583,932 →
Treatment of a Disease of the Gastrointestinal Tract with Live Biotherapeutics
Application:
62/596,040 →
Treatment of a Disease of the Gastrointestinal Tract with Live Biotherapeutics
Application:
62/598,948 →
Localization Systems and Methods for an Optoelectromechanical Pill Device
Application:
62/480,187 →
Localization Systems and Methods for an Ingestible Device
Application:
62/540,873 →
Localization Systems and Methods for an Ingestible Device
Localization Systems and Methods for an Ingestible Device
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application:
62/507,008 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application:
62/545,232 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application:
62/583,806 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Application:
62/598,957 →
Treatment of a Disease of the Gastrointestinal Tract with Il-10 or an Il-10 Agonist
Treatment of a Disease of the Gastrointestinal Tract with a CD40/CD40L Inhibitor
Application:
62/545,129 →
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent
Application:
62/583,921 →
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent
Application:
62/598,966 →
Treatment of a Disease of the Gastrointestinal Tract with an Immune Modulatory Agent Released Using an Ingestible Device
Application:
18/403,636 →
Publication:
US US20240335644A1
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/545,894 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/583,969 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/596,041 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/599,005 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/599,000 →
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/650,900 →
Ingestible Devices and Related Systems and Methods
Application:
62/560,618 →
Gastrointestinal Tract Detection Methods, Devices and Systems
Gastrointestinal Tract Detection Methods, Devices and Systems
Gastrointestinal Tract Detection Methods, Devices and Systems
Application:
18/826,061 →
Publication:
US US20250000364A1
Treatment of a Disease of the Gastrointestinal Tract with a Chemokine/Chemokine Receptor Inhibitor
Application:
62/583,929 →
System and Method of Sovereign Digital Identity Search and Bidirectional Matching
Application:
16/165,803 →
Publication:
US US20190121813A1
Ingestible Device and Associated Methods
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application:
62/622,639 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application:
62/650,850 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Application:
62/687,683 →
Treatment of a Disease of the Gastrointestinal Tract with a PDE4 Inhibitor
Ingestible Device with Relatively Large Payload Volume
Application:
62/642,544 →
Ingestible Device With Relatively Large Payload Volume
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application:
62/679,659 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application:
62/751,209 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application:
62/829,225 →
Devices and Systems for Gastrointestinal Microbiome Detection and Manipulation
Application:
17/059,058 →
Publication:
US US20210386367A1
Treatment of a Disease of the Gastrointestinal Tract with a S1P Modulator
Application:
62/687,697 →
Treatment of a Disease of the Gastrointestinal Tract with a S1P Modulator
Application:
16/769,983 →
Publication:
US US20220135666A1
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/687,429 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
62/804,828 →
Treatment of a Disease of the Gastrointestinal Tract with a Tnf Inhibitor
Application:
17/253,811 →
Publication:
US US20230312700A1
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/687,745 →
Treatment of a Disease of the Gastrointestinal Tract with an Il-12/Il-23 Inhibitor
Application:
62/804,840 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/687,546 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/786,275 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
62/805,099 →
Treatment of a Disease of the Gastrointestinal Tract with an Integrin Inhibitor
Application:
17/253,806 →
Publication:
US US20230033021A1
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/687,756 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak Inhibitor
Application:
62/804,385 →
Treatment of a Disease of the Gastrointestinal Tract with a Jak or Other Kinase Inhibitor
Treatment of a Disease of the Gastrointestinal Tract with a Jak or Other Kinase Inhibitor
Application:
19/001,302 →
Publication:
US 2026/0014156
Treatment of a Disease of the Gastrointestinal Tract with an Immunosuppressant
Application:
62/687,751 →
Treatment of a Disease of the Gastrointestinal Tract with an Immunomodulator
Application:
17/253,799 →
Publication:
US US20230041197A1
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
62/687,766 →
Method of Formulating a Pharmaceutical Composition Comprising Administering an Immune Modulator to the Intestine
Treatment of a Disease or Condition in a Tissue Originating from the Endoderm
Application:
19/041,919 →
Publication:
US US20260001946A1
Ingestible Device With High Pressure Substance Delivery to the Gastrointestinal Tract
Application:
62/769,496 →
Ingestible Device With High Pressure Substance Delivery to the Gastrointestinal Tract
Application:
62/818,731 →
Ingestible Device With High Pressure Substance Delivery to the Gastrointestinal Tract
Application:
62/819,513 →
Ingestible Device and Method of Use to Deliver Therapeutic Agent to the Gastrointestinal Tract
Application:
62/932,459 →
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Methods and Devices for Treating a Disease with Biotherapeutics
Application:
17/295,275 →
Publication:
US US20230023414A1
Methods and Devices for Treating a Disease with Biotherapeutics
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Application:
17/295,282 →
Publication:
US US20240252795A1
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Application:
62/948,082 →
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Application:
63/027,427 →
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Application:
63/086,630 →
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Methods of Treating and Predicting Non-response to Anti-TNF Treatment in Subjects with a Disease of the Gastrointestinal Tract
Application:
63/104,399 →
Methods of Treating and Predicting Non-Response to Anti-Tnf Treatment in Subjects with a Disease of the Gastrointestinal Tract
Application:
63/182,678 →
Methods of Treating and Predicting Non-Response to Anti-Tnf Treatment in Subjects with Gastrointestinal Tract Diseases
Application:
18/250,202 →
Publication:
US US20250325662A1
Aqueous Formulations of Tofacitinib and Tofacitinib Salts
Application:
63/242,436 →
Aqueous Formulations of Tofacitinib and Tofacitinib Salts
Application:
18/578,472 →
Publication:
US US20240299295A1
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Track
Application:
63/321,537 →
Ingestible Device for Delivery of Therapeutic Agent to the Gastrointestinal Tract
Application:
18/847,875 →
Publication:
US US20250195855A1
Trigger Assembly for Ingestible Drug Delivery Device
Application:
63/580,213 →
Ingestible Drug Delivery Device
Application:
63/584,466 →
Ingestible Drug Delivery Device
Application:
63/654,834 →
Active Agent Delivery Devices and Methods of Using the Same
Active Agent Delivery Devices and Methods of Using the Same
Active Agent Delivery Devices and Methods of Using the same
Application:
18/525,612 →
Publication:
US US20240108869A1
Electronically and Remotely Controlled Pill and System for Delivering at Least One Medicament
Electronically And Remotely Controlled Pill And System For Delivering At Least One Medicament
Electronic Gastrointestinal Screening
Device for Controlled Release of Chemical Molecules
Device for Drug Administration and/or Monitoring the Status of a Patient
Electronic Capsule for Treating Gastrointestinal Disease
Medicament Delivery System and Process
Medicament Delivery Apparatus
Miniaturized Threshold Sensor
Design of Swallowable Multi-Nozzle Dosing Device for Releasing Medicines in the Gastrointestinal Tract
Medicament Delivery Device, Capsule and in Vivo Medicine Delivery or Diagnostic System
Modular Ingestible Drug Delivery Capsule
Ingestible Electronic Capsule and in Vivo Drug Delivery or Diagnostic System
Electronic Pill Comprising a Medicine Reservoir
Medicine Reservoir for Drug Delivery Device
Drug Delivery Device with Compressible Drug Reservoir
Electronic Pill for Delivery of Powder Medication
Swallowable Medication Capsule
Drug Delivery Capsules With External Intelligence
Nucleic Acids and Methods for Detecting Chromosomal Abnormalities
Application:
62/198,654 →
Nucleic Acids and Methods for Detecting Chromosomal Abnormalities
Nucleic Acids and Methods for Detecting Chromosomal Abnormalities
Preeclampsia Markers
Application:
62/558,184 →
Preeclampsia Biomarkers and Related Systems and Methods
Preeclampsia Biomarkers and Related Systems and Methods
Application:
17/691,399 →
Publication:
US US20220268781A1
Detection of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Application:
62/943,739 →
Detection of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Application:
62/947,957 →
Assessment of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Assessment of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Assessment of Preeclampsia Using Assays for Free and Dissociated Placental Growth Factor
Application:
17/710,756 →
Publication:
US US20230052697A1
Non-Fungible Token (Nft) Generation for Secure Applications
Application:
18/643,446 →
Publication:
US US20240275585A1
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 22, 2012
From: AMOAKO-TUFFOUR, YAW; JONES, MITCHELL; PRAKASH, SATYA
To: MICROPHARMA LIMITED
Reel/Frame 028245/0392 →
Assignment of Assignor's Interest
Oct 30, 2014
From: JONES, MITCHELL LAWRENCE; LABBÉ, ALAIN; DRLIK, MARK SASHA; PROCH MCMECHAN, CHRISTIAN TERRY
To: MICROPHARMA LIMITED
Reel/Frame 034071/0606 →
Assignment of Assignor's Interest
May 8, 2015
From: AMOAKO-TUFFOUR, YAW; JONES, MITCHELL; PRAKASH, SATYA
To: MICROPHARMA LIMITED
Reel/Frame 035593/0568 →
Assignment of Assignor's Interest
Jun 12, 2015
From: MICROPHARMA LIMITED
To: INTERFACE THERAPEUTICS, INC.
Reel/Frame 035903/0232 →
Assignment of Assignor's Interest
Jun 30, 2015
From: INTERFACE THERAPEUTICS, INC.
To: PROGENITY, INC.
Reel/Frame 035942/0510 →
Assignment of Assignor's Interest
Apr 3, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 041831/0263 →
Assignment of Assignor's Interest
May 8, 2017
From: STYLLI, HARRY; SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 042421/0265 →
Assignment of Assignor's Interest
May 8, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 042278/0815 →
Assignment of Assignor's Interest
May 8, 2017
From: STYLLI, HARRY; SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 042278/0553 →
Assignment of Assignor's Interest
May 8, 2017
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY INC.
Reel/Frame 042278/0313 →
Assignment of Assignor's Interest
Nov 16, 2017
From: JONES, RYAN ELLIOTT; TANG, HAMILTON ROGER; GERVER, RACHEL ELLEN
To: PROGENITY INC.
Reel/Frame 044155/0067 →
Assignment of Assignor's Interest
Nov 30, 2017
From: SINGH, SHARAT
To: PROGENITY INC.
Reel/Frame 044264/0841 →
Assignment of Assignor's Interest
Jan 5, 2018
From: INTERFACE THERAPEUTICS, INC.
To: PROGENITY INC.
Reel/Frame 044544/0099 →
Assignment of Assignor's Interest
Jan 5, 2018
From: MICROPHARMA LIMITED
To: INTERFACE THERAPEUTICS, INC.
Reel/Frame 044543/0944 →
Assignment of Assignor's Interest
Jan 5, 2018
From: JONES, MITCHELL LAWRENCE; LABBÉ, ALAIN; DRLIK, MARK SASHA; PROCH MCMECHAN, CHRISTIAN TERRY
To: MICROPHARMA LIMITED
Reel/Frame 044543/0650 →
Assignment of Assignor's Interest
May 31, 2018
From: SINGH, SHARAT; JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN
To: PROGENITY INC.
Reel/Frame 045950/0689 →
Assignment of Assignor's Interest
Mar 11, 2019
From: JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN; WEY, GENE ALAN; PHILIPPSEN, AARON OLAFUR
To: PROGENITY INC.
Reel/Frame 048556/0668 →
Assignment of Assignor's Interest
Mar 14, 2019
From: JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN; PHILIPPSEN, AARON LAURENCE OLAFUR; ALLAN, NICHOLAS DAVID
To: PROGENITY, INC.
Reel/Frame 048594/0295 →
Corrective Assignment to Correct the Assignor Previously Recorded at Reel: 048556 Frame: 0668. Assignor(S) Hereby Confirms the Assignment.
Mar 19, 2019
From: JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN; WEY, GENE ALAN; PHILIPPSEN, AARON OLAFUR
To: PROGENITY, INC.
Reel/Frame 048638/0101 →
Assignment of Assignor's Interest
Jun 17, 2019
From: JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN; LILLIS, ALEC JOHN
To: PROGENITY, INC.
Reel/Frame 049488/0443 →
Corrective Assignment to Correct the Name of Aaron Olafur Laurence Phillippsen Previously Recorded on Reel 048594 Frame 0295. Assignor(S) Hereby Confirms the Assignment.
Sep 16, 2019
From: JONES, MITCHELL LAWRENCE; WAHL, CHRISTOPHER LOREN; PHILIPPSEN, AARON OLAFUR LAURENCE; ALLAN, NICHOLAS DAVID
To: PROGENITY, INC.
Reel/Frame 050387/0834 →
Assignment of Assignor's Interest
Jun 30, 2020
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY, INC.
Reel/Frame 053088/0274 →
Assignment of Assignor's Interest
Jul 1, 2020
From: JONES, MITCHELL LAWRENCE; SINGH, SHARAT; WAHL, CHRISTOPHER LOREN; STYLLI, HARRY
To: PROGENITY, INC.
Reel/Frame 053099/0404 →
Assignment of Assignor's Interest
Oct 2, 2020
From: MICROPHARMA LIMITED
To: INTERFACE THERAPEUTICS, INC.
Reel/Frame 053958/0494 →
Assignment of Assignor's Interest
Oct 2, 2020
From: INTERFACE THERAPEUTICS, INC.
To: PROGENITY INC.
Reel/Frame 053958/0581 →